CCMC Release

Clay County Medical Center has completed the first Inspire procedure. Inspire is
an FDA-approved obstructive sleep apnea (OSA) treatment option for people who cannot use
Continuous Positive Airway Pressure (CPAP) therapy.

OSA affects 22 million Americans. When left untreated, OSA can cause vehicle and workplace
accidents, worsening mood and memory, stroke, heart attack, and even death. It occurs when the
airway collapses during sleep and blocks the flow of oxygen to the brain. The brain senses a lack of
oxygen and wakes the body up just long enough to take a breath, then falls back asleep. This cycle
repeats throughout the night and causes poor, disruptive sleep.

Inspire works inside the body with a patient’s natural breathing process to treat sleep apnea. Mild
stimulation opens the airway during sleep, allowing oxygen to flow naturally. The patient uses a
small handheld remote to turn Inspire on before bed and off when they wake up.

The Inspire system is implanted during a short, outpatient procedure. The system is placed under the
skin of the neck and chest through two small incisions. Most patients return home the same day and
take over-the-counter pain medications to manage pain as needed.

The safety and efficacy of Inspire was evaluated during the STAR clinical trial. Five-year STAR trial
outcomes show patients using Inspire experience significant reductions in sleep apnea events and
significant improvements in quality-of-life measures. There have been over 150 peer-reviewed
publications on Inspire. These publications show results consistent with those seen in the STAR trial.

“We are excited to have completed the first Inspire procedure at Clay County Medical Center.” said
Eric Purdom, D.O. “Inspire represents a significant advancement in treating sleep apnea. It is
clinically proven to reduce sleep apnea events, has a high level of patient satisfaction and a high
therapy adherence.”

To learn more about Inspire, please visit InspireSleep.com or www.ccmcks.org.